Amgen ROE Ratio 2011-2026 | AMGN

Annual ROE Ratio Amgen

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
89.06	69.59	107.78	178.97	87.96	77.2	81.07	67.15	7.84	25.85	24.71	20.01	23.0	22.8	19.35

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
178.97	7.84	60.16

Quarterly ROE Ratio Amgen

2023-Q3	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
301.06	380.93	403.86	206.99	212.62	46.19	63.35	61.9	75.44	77.2	77.64	76.51	79.87	81.07	78.89	73.42	69.26	67.15	34.83	27.97	18.12	7.84	31.21	29.96	27.69	25.85	25.78	25.66	25.29	24.71	23.32	21.51	21.63	20.01	19.61	20.98	20.67	23.0	22.51	22.13	23.07	22.8	23.57	20.15	19.65	19.35	2.39	6.15	5.91

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
403.86	2.39	63.2

ROE Ratio of other stocks in the Biotechnology industry

Issuer	ROE Ratio	Price	% 24h	Market Cap	Country
MorphoSys AG MOR	15.76	-	2.43 %	$ 254 M	Germany
Acorda Therapeutics ACOR	160.08	-	-24.86 %	$ 820 K	USA
Adverum Biotechnologies ADVM	-185.15	-	-	$ 86.2 M	USA
AlloVir ALVR	-55.11	-	4.14 %	$ 49.1 M	USA
Amneal Pharmaceuticals AMRX	-101.78	$ 12.67	2.82 %	$ 3.97 B	USA
Applied Molecular Transport AMTI	-207.64	-	-	$ 10.1 M	USA
Applied Therapeutics APLT	698.49	-	-	$ 8.42 M	USA
I-Mab IMAB	-85.31	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	5.18	-	-	$ 40.3 B	USA
Genfit SA GNFT	626.29	-	2.54 %	$ 160 B	France
Arcutis Biotherapeutics ARQT	-8.52	$ 24.45	5.07 %	$ 3.11 B	USA
Biophytis SA BPTS	-751.94	-	-13.47 %	$ 169 M	France
AVROBIO AVRO	12.83	-	1083.1 %	$ 745 M	USA
Ayala Pharmaceuticals AYLA	3458.87	-	-	$ 7.46 M	Israel
AstraZeneca PLC AZN	20.44	-	-	$ 96.9 B	Britain
Midatech Pharma plc MTP	-330.29	-	-18.52 %	$ 27.3 M	Britain
EyeGate Pharmaceuticals, Inc. EYEG	-115.61	-	-1.52 %	$ 24.7 M	USA
Autolus Therapeutics plc AUTL	-161.42	$ 1.47	8.17 %	$ 391 M	Britain
BeiGene, Ltd. BGNE	6.58	-	0.49 %	$ 251 B	Cayman-islands
Alterity Therapeutics Limited ATHE	-36.22	$ 3.83	1.86 %	$ 9.21 B	Australia
BioNTech SE BNTX	1.11	$ 91.3	1.87 %	$ 27.2 B	Germany
CymaBay Therapeutics CBAY	-36.05	-	-	$ 3.45 B	USA
Advaxis ADXS	196.88	-	-9.65 %	$ 45.9 M	USA
Aytu BioScience AYTU	-71.51	$ 2.72	5.84 %	$ 17.1 M	USA
Burford Capital Limited BUR	10.1	$ 4.59	0.88 %	$ 742 M	Britain
Avid Bioservices CDMO	-231.16	-	-	$ 789 M	USA
Cidara Therapeutics CDTX	-103.99	-	-	$ 1.41 B	USA
Институт стволовых клеток человека ISKJ	17.55	-	-	-	Russia
Cabaletta Bio CABA	-149.8	$ 3.07	-	$ 308 M	USA
Can-Fite BioPharma Ltd. CANF	-144.96	$ 3.08	1.65 %	$ 6.7 B	Israel
Checkpoint Therapeutics CKPT	445.47	-	-	$ 169 M	USA
Cerus Corporation CERS	-24.33	$ 1.93	4.89 %	$ 368 M	USA
Aeterna Zentaris AEZS	-401.79	-	5.93 %	$ 314 M	Canada
Checkmate Pharmaceuticals CMPI	-88.4	-	-	$ 231 M	USA
AgeX Therapeutics AGE	51843.24	-	-10.17 %	$ 12.2 K	USA
Concert Pharmaceuticals CNCE	-71.33	-	-	$ 401 M	USA
Aeglea BioTherapeutics AGLE	-21.7	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	-62.37	-	-	$ 26.5 M	USA
CTI BioPharma Corp. CTIC	529.06	-	-	$ 1.2 B	USA
AIkido Pharma AIKI	-32.34	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	93.75	-	-45.71 %	$ 1.2 M	Canada
Cyclacel Pharmaceuticals CYCCP	-43.82	-	-4.36 %	$ 27 M	USA
Cellectar Biosciences CLRB	-255.25	$ 2.82	2.55 %	$ 7.36 M	USA
Deciphera Pharmaceuticals DCPH	-55.55	-	-	$ 2.18 B	USA
Akero Therapeutics AKRO	-33.6	-	-	$ 3.67 B	USA
Dynavax Technologies Corporation DVAX	4.58	-	-	$ 2.02 B	USA
CureVac N.V. CVAC	-59.8	-	-	$ 867 M	Germany
Cyclerion Therapeutics CYCN	-34.54	$ 3.47	-0.29 %	$ 8.74 M	USA